Constarium
← Search

Data · dataset · 2025

Gelatin/Polyethylene glycol/g-C3N4 hydrogel with olive oil as a sustainable and biocompatible nanovehicle for targeted delivery of 5-fluorouracil

Listed in e-cienciaDatos

In this project, a novel, sustainable and pH-sensitive nanocomposite was designed for the targeted delivery of 5-fluorouracil (5-FU) against breast cancer cells.

Description

The nanodelivery system is based on graphitic carbon nitride (g-C3N4) coated with Gelatin (G)/Polyethylene glycol (PEG) biopolymers, and was prepared by W/O/W double emulsion technique using olive oil and span 80 surfactant. Successful loading of 5-FU into the nanovehicle was confirmed by infrared spectroscopy and X-ray diffraction analyses.

VDynamic light scattering corroborated the monodispersity of the nanocarriers, with a typical size between 250 and 300 nm. Scanning electron microscopy images revealed the homogeneity of the nanocomposite and its spherical shape. The average zeta potential was +35.4 mV, demonstrating the good stability of the nanocomposite.

Read the rest (2 more)

The drug loading (47%) and encapsulation efficiency (89%) were higher than those reported for other 5-FU nanocarriers. A continuous and controlled 5-FU release from the nanovehicle was observed, and the release rate at pH 5.4 (simulating a cancerous environment) was higher than at pH 7.4 (physiological conditions). Kinetic studies suggested a diffusion controlled mechanism of 5-FU release from the nanocarrier in an acidic environment, while an anomalous transport prevails at neutral pH.

The MTT assay revealed that G/PEG/g-C3N4 had a significant cytotoxicity on MCF-7 breast cancer cells. Flow cytometry indicated that G/PEG/g-C3N4/5-FU led to much higher apoptotic percentage than free 5-FU, while the free drug showed higher percentage of necroptotic cells.

Links

Where it is published

Catalogue records · 1

Topics

Stated by source
Química
Inferred from text
Cancer 75% · Image 65% · Medicinal and biomolecular chemistry 72% · Microscopy 75%
Provenance · 1 source records, 11 field assertions
SourceKeyLast seenRaw
e-cienciaDatosdoi:10.21950/6ODJOP11 d agoJSON v1
FieldAssertionExtractorEvidence
concepts[disease].local:disease:cancerenrichment · edatos consorciomadrono eskeyword-concept-rules@1.0.0title+description (75%)
concepts[field].anzsrc:group:3404enrichment · edatos consorciomadrono estaxonomy-embedding@1.1.0title+keywords+description (72%)
concepts[field].dataverse_subject:qu-micasource · edatos consorciomadrono esconnector:edatos_consorciomadrono_es@1.0.0/subjects
concepts[modality].local:modality:imageenrichment · edatos consorciomadrono eskeyword-concept-rules@1.0.0title+description (65%)
concepts[modality].local:modality:microscopyenrichment · edatos consorciomadrono eskeyword-concept-rules@1.0.0title+description (75%)
created_datesource · edatos consorciomadrono esconnector:edatos_consorciomadrono_es@1.0.0
descriptionsource · edatos consorciomadrono esconnector:edatos_consorciomadrono_es@1.0.0/description
publication_datesource · edatos consorciomadrono esconnector:edatos_consorciomadrono_es@1.0.0
titlesource · edatos consorciomadrono esconnector:edatos_consorciomadrono_es@1.0.0/name
updated_datesource · edatos consorciomadrono esconnector:edatos_consorciomadrono_es@1.0.0
version_labelsource · edatos consorciomadrono esconnector:edatos_consorciomadrono_es@1.0.0